Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DV Biomed CoROCO:6539 66 PB Ratio is 1.92 as of Jul. 29, 2026, which is 42% below its 10-year median of 3.30. GuruFocus rates ROCO:6539 with a GF Score™ of 66/100 and a GF Value™ of NT$69.63 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 921 Drug Manufacturers companies, DV Biomed Co ranks worse than 50.81% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-29), DV Biomed Co's share price is NT$40.00. DV Biomed Co's Book Value per Share for the quarter that ended in Dec. 2025 was NT$20.84. Hence, DV Biomed Co's PB Ratio of today is 1.92.
The historical rank and industry rank for DV Biomed Co's PB Ratio or its related term are showing as below:
ROCO:6539'
s PB Ratio Range Over the Past 10 Years
Min: 0.77 Med: 3.3 Max: 12.81
Current: 1.92
During the past 13 years, DV Biomed Co's highest PB Ratio was 12.81. The lowest was 0.77. And the median was 3.30.
ROCO:6539's PB Ratio is ranked worse than 50.81% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.9
vs ROCO:6539: 1.92
During the past 12 months, DV Biomed Co's average Book Value Per Share Growth Rate was -67.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -7.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -9.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -0.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of DV Biomed Co was 88.60% per year. The lowest was -26.30% per year. And the median was 10.85% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
DV Biomed Co PB Ratio Related Terms
DV Biomed Co PB Ratio Historical Data
* Premium members only.
The historical data trend for DV Biomed Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DV Biomed Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DV Biomed Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DV Biomed Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where DV Biomed Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
DV Biomed Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
DV Biomed Co (ROCO:6539) has a PB Ratio of 1.92 as of Jul. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on DV Biomed Co and its competitors. This is 42% below median its historical median of 3.30. Over the past decade, DV Biomed Co's PB Ratio has ranged from 0.77 to 12.81. According to the industry distribution chart, DV Biomed Co ranks #468 out of 921 companies in the Drug Manufacturers industry, placing it in the top 50.8%.
Is DV Biomed Co's PB Ratio too high?
DV Biomed Co's current PB Ratio of 1.92 is 42% below median its 10-year median of 3.30. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 12.81. The Drug Manufacturers industry median PB Ratio is 1.90. DV Biomed Co's value of 1.92 is 1.1% above this industry median. Based on the distribution chart, DV Biomed Co ranks #468 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DV Biomed Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DV Biomed Co's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DV Biomed Co ranks #468 out of 921 companies for PB Ratio. This places DV Biomed Co in the lower half of its industry. The industry median PB Ratio is 1.90. DV Biomed Co's value of 1.92 is 1.1% above this benchmark. Historically, DV Biomed Co's own PB Ratio has ranged from 0.77 to 12.81 over the past decade. While the company's 10-year median is 3.30 vs. the industry median of 1.90, DV Biomed Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.90, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DV Biomed Co's current PB Ratio of 1.92 is 1.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on DV Biomed Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DV Biomed Co's current PB Ratio is 1.92, which is 42% below median its own 10-year median of 3.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DV Biomed Co stock overvalued right now?
Based on GuruFocus' analysis, DV Biomed Co (ROCO:6539) is currently considered Possible Value Trap. The stock's GF Value™ is NT$69.63, compared to a current price of NT$40.00 — trading 42.6% below its estimated fair value. The current PB Ratio is 1.92, which is 42% below median its 10-year median of 3.30 and 1.1% above the Drug Manufacturers industry median of 1.90. DV Biomed Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For DV Biomed Co (ROCO:6539), the current PB Ratio is 1.92 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DV Biomed Co (ROCO:6539) Overvalued in 2026?
Based on GuruFocus' analysis, DV Biomed Co stock appears to be undervalued.
The current stock price of NT$40.00 is trading 42.6% below its estimated GF Value™ of NT$69.63.
GuruFocus considers DV Biomed Co to be Possible Value Trap.
Key valuation signals for ROCO:6539:
PB Ratio: 1.92 (42% below median its 10-year median of 3.30)
GF Value™: NT$69.63 vs. price of NT$40.00 (42.6% below fair value)
Industry Position: 1.1% above the Drug Manufacturers median (#468 of 921)
No single metric tells the full story. See the ROCO:6539 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DV Biomed Co Ltd provides medical supplies, skincare, and healthcare products. Its products include Perfectin and L'AMOUR Isis. The company also provides medical materials and needles (medicine), and healthcare products.
66GF Score
Get the complete analysis for ROCO:6539
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6539 has been successfully added to your 
